Anti-inflammatory and immunomodulatory effects of statins

This publication has 103 references indexed in Scilit:

• Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells
  Atherosclerosis, 2002
• Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells
  Life Sciences, 2000
• Cerivastatin Suppresses Lipopolysaccharide-Induced ICAM-1 Expression through Inhibition of Rho GTPase in BAEC
  Biochemical and Biophysical Research Communications, 2000
• The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis
  Journal of Biological Chemistry, 1997
• Inhibitory effect of fluvastatin, an HMG-CoA reductase inhibitor, on the expression of adhesion molecules on human monocyte cell line
  International Journal of Immunopharmacology, 1996
• Comparison of coronary lesions obtained by directional coronary atherectomy in unstable angina, stable angina, and restenosis after either atherectomy or angioplasty
  The American Journal of Cardiology, 1995
• The acute phase response
  Immunology Today, 1994
• HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Regulation of the mevalonate pathway
  Nature, 1990
• Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by lovastatin
  International Journal of Immunopharmacology, 1989